| ￥3500 | |
| Z06071-100 | |
|
|
|
|
|
|
|
|
|
| Species | Mouse | ||||
| Protein Construction |
|
||||
| Purity |
> 90% as determined by BisTris PAGE > 90% as determined by HPLC |
||||
| Endotoxin Level | Less than 1EU per μg by the LAL method. | ||||
| Expression System | HEK293 | ||||
| Theoretical Molecular Weight | 66.39 kDa | ||||
| Apparent Molecular Weight | Due to autocatalytic cleavage and glycosylation, the protein migrates to 80-100 kDa on Bis-Tris PAGE result. | ||||
| Formulation | Lyophilized from 0.22μm filtered solution in 50mM Tris, 150mM NaCl (pH 8.0). | ||||
| Reconstitution | Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in distilled water. | ||||
| Storage & Stability | Upon receiving, the product remains stable up to 6 months at -20 °C or below. Upon reconstitution, the product should be stable for 3 months at -80 °C. Avoid repeated freeze-thaw cycles. |
The purity of Complement factor I, His, Mouse is greater than 90% as determined by SEC-HPLC. »
Complement factor I, His, Mouse on Bis-Tris PAGE under reduced condition. The purity is greater than 90%. »
| Target Background | Complement factor I (CFI) is a serine protease which plays a key role in the modulation of complement system and the induced-fit factor responsible for controlling the complement-mediated processes. |
| Synonyms | C3B/C4B inactivator; CFI; IF; C3BINA; FIC3b-INA; I factor (complement); KAF |
For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.
